BIO-key International, Inc.
BIO-key International, Inc. (BKYI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bkyi · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $4.13
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BKYI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-03-25 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2020-11-25 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2020-11-25 | Maxim Group | Maintains | Buy→Buy |
| 2019-10-03 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2018-08-15 | Maxim Group | Maintains | Buy→Buy |
| 2017-07-13 | Maxim Group | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on BIO-key International, Inc. (BKYI) stock. Of the recent 6 rating actions, 1 were upgrades and 2 were downgrades. 1 analysts currently cover BKYI.
Analyst Recommendation Trends
BKYI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$9M
↑ 23.3% YoY
Revenue Next Year
$8M
↓ 13.3% YoY
EPS This Year
$-5.22
EPS Next Year
$-18.60
↑ 256.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast BKYI EPS of $-5.22 for the current fiscal year, based on estimates from 1 analysts. The BKYI revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BKYI stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BKYI price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
BIO-key International, Inc. trades on NASDAQ under the ticker BKYI. The BKYI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BKYI forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month BKYI price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $4.13.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.